BELITE BIO INC - AMER
67.44
27-11月-24 16:45:00
15 分の遅延
株式
+3.42
+5.34%
本日の幅
62.53 - 70.00
ISIN
N/A
ソース
NASDAQ
-
Belite Bio Announces $25 Million Registered Direct Offering
25 4 2024 19:15:29 提供 Nasdaq GlobeNewswire
-
Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in Japan
22 3 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Belite Bio Announces Availability of Annual Report on Form 20-F Through Company Website
11 3 2024 22:28:39 提供 Nasdaq GlobeNewswire
-
Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
11 3 2024 21:27:47 提供 Nasdaq GlobeNewswire
-
06 3 2024 08:00:01 提供 Nasdaq GlobeNewswire
-
Belite Bio to Participate in the Leerink Partners Global Biopharma Conference
04 3 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
07 2 2024 08:00:00 提供 Nasdaq GlobeNewswire
-
30 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Belite Bio to Participate in the BTIG Ophthalmology Day
20 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial Results
13 11 2023 20:15:47 提供 Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial Results
07 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
06 11 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Belite Bio Announces Presentation at the American Academy of Ophthalmology 2023 Annual Meeting
27 10 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Belite Bio Reports Second Quarter 2023 Operational Highlights and Financial Results
08 8 2023 22:17:28 提供 Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on August 9, 2023 to Discuss Second Quarter 2023 Financial Results
04 8 2023 08:00:00 提供 Nasdaq GlobeNewswire
-
Belite Bio Doses First Subject in Pivotal Phase 3 PHOENIX Trial Evaluating Oral Tinlarebant for GA
27 7 2023 17:00:00 提供 Nasdaq GlobeNewswire
-
30 5 2023 20:49:26 提供 Nasdaq GlobeNewswire
-
30 5 2023 16:01:00 提供 Nasdaq GlobeNewswire
-
Belite Bio Reports First-Quarter 2023 Operational Highlights and Financial Results
10 5 2023 19:58:59 提供 Nasdaq GlobeNewswire
-
Belite Bio to Host Webcast on May 11, 2023 to Discuss First Quarter 2023 Financial Results
10 5 2023 15:33:22 提供 Nasdaq GlobeNewswire